NXG
NexgenRx
Stock
Stock
ISIN: CA65337X1042
Ticker: NXG
CA65337X1042
NXG
Price
Price
CHART BY
Historical dividends and forecast
NexgenRx has so far distributed $0.0109 in 2024. The next dividend will be paid on 04.01.2025
$0.008163
CHART BY
Frequently asked questions
What is NexgenRx's market capitalization?
The market capitalization of NexgenRx is $12.63M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is NexgenRx's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for NexgenRx is 70.83. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for NexgenRx?
NexgenRx's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.002438. EPS indicates the company's profitability on a per-share basis.
What is NexgenRx's revenue over the trailing twelve months?
Over the trailing twelve months, NexgenRx reported a revenue of $10.80M.
What is the EBITDA for NexgenRx?
NexgenRx's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $794.28K. EBITDA measures the company's overall financial performance.
What is the free cash flow of NexgenRx?
NexgenRx has a free cash flow of $278.76K. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of NexgenRx's shares?
The free float of NexgenRx is 44.51M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $12.63M
- EPS (TTM)
- $0.002438
- Free Float
- 44.51M
- P/E ratio (TTM)
- 70.83
- Revenue (TTM)
- $10.80M
- EBITDA (TTM)
- $794.28K
- Free Cashflow (TTM)
- $278.76K
Pricing
- 52W span
- $0.129$0.252
Information
NexgenRx, Inc. engages in the provision of administrative services only (ASO) (Self-Funded) drug, dental and extended health benefit plans supported by technology. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company was founded by Ronald Campbell Loucks on March 13, 2003 and is headquartered in Toronto, Canada.
- Industries
- Miscellaneous Commercial Services
- Sector
- Health Care
Identifier
- ISIN
- CA65337X1042
- Primary Ticker
- NXG